Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Acid Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117362252B details a bio-based furan route to FDCM. Offers safer Claisen reaction and scalable polymer intermediate production for global supply chains.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN109134485B reveals a high-yield isosorbide synthesis using 1,4-sorbitan and solid acids. Discover cost-effective, scalable bio-based manufacturing solutions.
Patent CN103524308B reveals solid acid catalysis for high-purity halogenated phenol manufacturing with reduced waste and enhanced supply chain reliability.
Patent CN1332948C details a solvent-free synthesis of bis-indolyl derivatives using SO4 2-/TiO2, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN102040572A details a green synthesis of benzofuranone using cationic resin, offering high purity and reduced corrosion for azoxystrobin manufacturing.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Patent CN111560005A details green synthesis of 2-thiopheneacetyl chloride offering high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN105541773A details a green synthesis route for 3,4-dihydro-4-arylcoumarins using recyclable catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110218234A reveals safer Promestriene synthesis. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable solid acid catalysis.
Patent CN111187264A introduces a resin-catalyzed cyclization for mirtazapine, eliminating sulfuric acid waste and simplifying purification for reliable pharmaceutical intermediate supply.
Novel solid superacid catalysis method for Tinidazole reduces waste and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN111559959A introduces a green synthesis route for p-trifluoromethylphenol using cation exchange resin, offering significant cost reduction and simplified purification for industrial manufacturing.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN101417910A details solid acid catalysis for prazole nitration, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111170958A details a green solid-acid catalyzed route for hydroxybenzomorph, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103665078B reveals a safer synthesis route for steroidal esters. This method avoids hazardous reagents, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102746260A details an eco-friendly synthesis of benzofuran-2(3H)-one using silica sulfonic acid. This method offers high conversion, catalyst recyclability, and reduced waste for pharma intermediates.
Patent CN102617312B reveals a greener synthesis route for 2-chloro-6-fluorobenzaldehyde using ferric solid superacid, offering significant cost reduction and higher purity for API intermediates.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.